查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1951824

基因組編輯工具市場分析及預測（至2035年）：類型、產品類型、服務、技術、應用、最終用戶、組件、流程、功能、設備

Genomic Editing Tools Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Application, End User, Component, Process, Functionality, Equipment
出版日期: | 出版商: Global Insight Services | 英文 354 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

基因組編輯工具市場預計將從2024年的109億美元成長到2034年的513億美元，複合年成長率約為20%。基因組編輯工具市場涵蓋了能夠實現精確DNA修飾的技術，例如CRISPR、TALEN和ZFN。這些工具透過支持基因治療、作物改良和合成生物學，促進了醫學、農業和生物技術領域的進步。市場成長的促進因素包括對個人化醫療日益成長的需求、研發投入的增加以及監管政策的調整。創新重點在於提高精準度、效率和倫理考量，凸顯了基因組編輯在應對全球健康和糧食安全挑戰方面的變革性潛力。

基因組編輯工具市場呈現強勁成長勢頭，這主要得益於生物技術的進步和醫療保健領域應用的不斷拓展。 CRISPR技術憑藉其基因編輯的精準性和高效性，成為表現最佳的細分市場；其次是TALEN和ZFN技術，它們為複雜的基因修飾提供了替代解決方案。治療應用領域佔據主導地位，這主要得益於個人化醫療和罕見疾病基因治療領域的創新。農業應用領域表現排名第二，反映了市場對改良作物性狀和永續農業實踐日益成長的需求。科研機構和學術機構是重要的貢獻者，它們不斷探索基因組編輯的新可能性。新型遞送系統的開發實現了靶向高效的基因編輯，進一步增強了市場動態。倫理考量和法規結構正在重塑市場格局，凸顯了負責任創新的必要性。人工智慧和生物資訊學的融合有望徹底改變基因組編輯領域，並釋放新的成長潛力。

市場區隔
類型 CRISPR、TALEN、鋅指核酸酶、Meganucleases
產品 試劑、試劑盒、設備和軟體
服務 客製化服務、諮詢服務、驗證服務
科技 基因敲除、基因敲入、基因靜默、基因編輯
應用領域 臨床應用、科學研究應用、農業應用、工業應用
最終用戶 生技公司、製藥公司、學術機構、研究機構
成分 DNA模板、引導RNA、核酸酶、修復模板
過程 體內、試管內、離體
功能 基因破壞、基因校正、基因插入
裝置 定序儀、轉染裝置、細胞分選儀

基因組編輯工具市場競爭格局活躍，主要生物技術公司佔據顯著的市場佔有率。定價策略不斷演變，反映了創新產品的推出和精準醫療需求的日益成長。頻繁的新產品發布凸顯了CRISPR技術和其他基因編輯平台的快速發展。在技​​術進步和研究經費增加的推動下，市場正朝著更具成本效益和效率的解決方案轉型。基因組編輯工具領域的競爭異常激烈，多家主要企業透過策略聯盟和收購爭奪主導。法規結構，尤其是在北美和歐洲，在塑造市場動態發揮關鍵作用。這些法規確保了倫理標準和安全性，並影響技術應用的速度。由於遺傳疾病的增加以及基因組編輯在農業和治療領域的應用不斷擴展，市場呈現成長跡象。持續的技術創新和合規性對於保持競爭優勢和促進市場擴張仍然至關重要。

主要趨勢和促進因素：

受CRISPR技術進步和研發投入增加的推動，基因組編輯工具市場正經歷強勁成長。一個關鍵趨勢是將人工智慧和機器學習結合，以提高基因編輯的精確度和效率。這種技術協同作用正在簡化研發流程並縮短研發週期。此外，隨著醫療保健向個人化治療方案轉變，個人化醫療的興起正在推動對基因組編輯工具的需求。農業領域也是一個重要的促進因素，基因組編輯工具正被用於培育更具抗逆性和環境脅迫性的作物。在面臨氣候變遷挑戰的地區，這趨勢尤其明顯。此外，監管支持和政府對生物技術研究的資助也在推動市場成長。新興市場生物技術基礎設施的快速發展為眾多機會提供了可能，吸引投資並鼓勵創新。此外，倫理和安全的考量正在塑造市場格局，促使企業投資開發更安全、更精確的編輯技術。隨著公眾意識和接受度的提高，基因組編輯工具的潛在應用範圍正在擴大，涵蓋醫療保健和農業以外的許多行業。在技​​術不斷進步和跨學科合作日益密切的推動下，市場有望持續成長。

目錄

第1章執行摘要

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制
  • 複合年均成長率：成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章 細分市場分析

  • 市場規模及預測：依類型
    • CRISPR
    • TALENs
    • 鋅指核酸酶
    • Meganucleases
  • 市場規模及預測：依產品分類
    • 試劑
    • 成套工具
    • 裝置
    • 軟體
  • 市場規模及預測：依服務分類
    • 客戶服務
    • 諮詢服務
    • 檢驗服務
  • 市場規模及預測：依技術分類
    • 基因敲除
    • 基因敲入
    • 基因靜默
    • 基因編輯
  • 市場規模及預測：依應用領域分類
    • 臨床應用
    • 研究用途
    • 農業應用
    • 工業應用
  • 市場規模及預測：依最終用戶分類
    • 生技公司
    • 製藥公司
    • 學術機構
    • 研究所
  • 市場規模及預測：依組件分類
    • DNA模板
    • 引導RNA
    • 核酸酶
    • 修復模板
  • 市場規模及預測：依製程分類
    • In vivo
    • 體外
    • Ex Vivo
  • 市場規模及預測：依功能分類
    • 基因破壞
    • 基因校正
    • 基因轉移
  • 市場規模及預測：依設備分類
    • 序列器
    • 轉染裝置
    • 細胞分選裝置

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地區
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲地區

第6章 市場策略

  • 需求與供給差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 法規概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 主要企業的策略

第8章 公司簡介

  • Editas Medicine
  • Intellia Therapeutics
  • CRISPR Therapeutics
  • Beam Therapeutics
  • Sangamo Therapeutics
  • Precision Bio Sciences
  • Caribou Biosciences
  • Cellectis
  • Gen Edit
  • Poseida Therapeutics
  • Horizon Discovery
  • Inscripta
  • Synthego
  • Mammoth Biosciences
  • e Genesis
  • Ori Gene Technologies
  • Agenovir Corporation
  • Recombinetics
  • Telesis Bio
  • Pairwise

第9章：關於我們

簡介目錄
Product Code: GIS32780

Genomic Editing Tools Market is anticipated to expand from $10.9 billion in 2024 to $51.3 billion by 2034, growing at a CAGR of approximately 20%. The Genomic Editing Tools Market encompasses technologies enabling precise DNA modification, including CRISPR, TALENs, and ZFNs. These tools facilitate advancements in medicine, agriculture, and biotechnology by enabling gene therapy, crop enhancement, and synthetic biology. The market is driven by rising demand for personalized medicine, increased R&D investments, and regulatory advancements. Innovations focus on improving accuracy, efficiency, and ethical considerations, underscoring the transformative potential of genomic editing in addressing global health and food security challenges.

The Genomic Editing Tools Market is experiencing robust growth, propelled by advancements in biotechnology and increasing applications in healthcare. The CRISPR segment is the top-performing sub-segment, owing to its precision and efficiency in gene editing. TALENs and ZFNs follow, offering alternative solutions for complex genetic modifications. The therapeutics application segment leads, driven by innovations in personalized medicine and gene therapies targeting rare diseases. Agricultural applications are the second highest-performing segment, reflecting the growing need for enhanced crop traits and sustainable farming practices. Research and academic institutions are significant contributors, as they continue to explore new genomic editing possibilities. The development of novel delivery systems is further enhancing market dynamics, enabling targeted and efficient gene editing. Ethical considerations and regulatory frameworks are shaping the market landscape, emphasizing the need for responsible innovation. The integration of AI and bioinformatics is poised to revolutionize the genomic editing field, unlocking new opportunities for growth.

Market Segmentation
TypeCRISPR, TALENs, Zinc Finger Nucleases, Meganucleases
ProductReagents, Kits, Instruments, Software
ServicesCustom Services, Consultation Services, Validation Services
TechnologyGene Knockout, Gene Knock-in, Gene Silencing, Gene Editing
ApplicationClinical Applications, Research Applications, Agricultural Applications, Industrial Applications
End UserBiotechnology Companies, Pharmaceutical Companies, Academic Institutions, Research Laboratories
ComponentDNA Templates, Guide RNA, Nucleases, Repair Templates
ProcessIn Vivo, In Vitro, Ex Vivo
FunctionalityGene Disruption, Gene Correction, Gene Insertion
EquipmentSequencers, Transfection Equipment, Cell Sorters

The Genomic Editing Tools Market is characterized by a dynamic competitive landscape with significant market share held by leading biotechnology firms. Pricing strategies are evolving, reflecting the introduction of innovative products and the increasing demand for precision medicine. New product launches are frequent, highlighting the rapid advancements in CRISPR technology and other gene-editing platforms. The market is witnessing a shift towards more cost-effective and efficient solutions, driven by technological advancements and increased research funding. Competition within the genomic editing tools sector is intense, with several key players striving for dominance through strategic alliances and acquisitions. Regulatory frameworks, particularly in North America and Europe, play a crucial role in shaping market dynamics. These regulations ensure ethical standards and safety, influencing the pace of technological adoption. The market is poised for growth, propelled by the rising prevalence of genetic disorders and the expanding applications of genomic editing in agriculture and therapeutics. Continuous innovation and regulatory compliance remain pivotal in maintaining competitive advantage and fostering market expansion.

Geographical Overview:

The genomic editing tools market is witnessing a dynamic expansion across various regions, each presenting unique growth opportunities. North America dominates the market, driven by substantial investments in biotechnology and a robust research ecosystem. The presence of leading biotech firms and academic institutions further enhances the region's market position. Europe is emerging as a significant player, bolstered by strong regulatory frameworks and public funding for genomic research. The region's focus on precision medicine and personalized healthcare propels market growth. In Asia Pacific, the market is rapidly expanding, fueled by increasing government support and growing biotechnology industries. Countries like China and India are at the forefront, harnessing genomic editing technologies to advance healthcare solutions. Latin America and the Middle East & Africa are nascent markets with promising potential. Brazil is investing in biotech innovations, while countries in the Middle East are recognizing the strategic importance of genomic editing in advancing medical research and healthcare outcomes.

Global tariffs and geopolitical tensions are profoundly impacting the Genomic Editing Tools Market, particularly in Japan, South Korea, China, and Taiwan. Japan and South Korea are enhancing domestic R&D to mitigate reliance on imported genomic technologies, while China accelerates its focus on self-sufficiency amid export restrictions. Taiwan, pivotal in biotech manufacturing, navigates US-China tensions with strategic alliances. The parent market is experiencing robust growth, driven by advances in CRISPR and gene therapy. By 2035, the market is poised for exponential expansion, contingent on geopolitical stability and innovation in supply chains. Middle Eastern conflicts further complicate supply chains, influencing energy prices and operational costs, thereby necessitating resilient strategies to ensure market sustainability and growth.

Key Trends and Drivers:

The genomic editing tools market is experiencing robust growth, fueled by advancements in CRISPR technology and increasing research investments. Key trends include the integration of AI and machine learning for enhanced precision and efficiency in gene editing. This technological synergy is streamlining processes and reducing timeframes for research and development. Furthermore, the rise of personalized medicine is driving demand for genomic editing tools, as healthcare shifts towards tailored therapeutic solutions. The agricultural sector is also a significant driver, with genome editing tools being utilized to develop crops with improved yield and resistance to environmental stressors. This trend is particularly pronounced in regions facing climate change challenges. Additionally, regulatory support and government funding for biotechnological research are bolstering market growth. Opportunities abound in emerging markets where biotechnology infrastructure is rapidly developing, attracting investments and fostering innovation. Moreover, ethical and safety considerations are shaping the market landscape, prompting companies to invest in developing safer and more precise editing techniques. As public awareness and acceptance grow, the potential applications of genomic editing tools are expanding, encompassing a wide range of industries beyond healthcare and agriculture. The market is poised for sustained growth, driven by continued technological advancements and increasing interdisciplinary collaborations.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by End User
  • 2.7 Key Market Highlights by Component
  • 2.8 Key Market Highlights by Process
  • 2.9 Key Market Highlights by Functionality
  • 2.10 Key Market Highlights by Equipment

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 CRISPR
    • 4.1.2 TALENs
    • 4.1.3 Zinc Finger Nucleases
    • 4.1.4 Meganucleases
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Reagents
    • 4.2.2 Kits
    • 4.2.3 Instruments
    • 4.2.4 Software
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Custom Services
    • 4.3.2 Consultation Services
    • 4.3.3 Validation Services
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Gene Knockout
    • 4.4.2 Gene Knock-in
    • 4.4.3 Gene Silencing
    • 4.4.4 Gene Editing
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Clinical Applications
    • 4.5.2 Research Applications
    • 4.5.3 Agricultural Applications
    • 4.5.4 Industrial Applications
  • 4.6 Market Size & Forecast by End User (2020-2035)
    • 4.6.1 Biotechnology Companies
    • 4.6.2 Pharmaceutical Companies
    • 4.6.3 Academic Institutions
    • 4.6.4 Research Laboratories
  • 4.7 Market Size & Forecast by Component (2020-2035)
    • 4.7.1 DNA Templates
    • 4.7.2 Guide RNA
    • 4.7.3 Nucleases
    • 4.7.4 Repair Templates
  • 4.8 Market Size & Forecast by Process (2020-2035)
    • 4.8.1 In Vivo
    • 4.8.2 In Vitro
    • 4.8.3 Ex Vivo
  • 4.9 Market Size & Forecast by Functionality (2020-2035)
    • 4.9.1 Gene Disruption
    • 4.9.2 Gene Correction
    • 4.9.3 Gene Insertion
  • 4.10 Market Size & Forecast by Equipment (2020-2035)
    • 4.10.1 Sequencers
    • 4.10.2 Transfection Equipment
    • 4.10.3 Cell Sorters

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Application
      • 5.2.1.6 End User
      • 5.2.1.7 Component
      • 5.2.1.8 Process
      • 5.2.1.9 Functionality
      • 5.2.1.10 Equipment
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Application
      • 5.2.2.6 End User
      • 5.2.2.7 Component
      • 5.2.2.8 Process
      • 5.2.2.9 Functionality
      • 5.2.2.10 Equipment
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Application
      • 5.2.3.6 End User
      • 5.2.3.7 Component
      • 5.2.3.8 Process
      • 5.2.3.9 Functionality
      • 5.2.3.10 Equipment
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Application
      • 5.3.1.6 End User
      • 5.3.1.7 Component
      • 5.3.1.8 Process
      • 5.3.1.9 Functionality
      • 5.3.1.10 Equipment
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Application
      • 5.3.2.6 End User
      • 5.3.2.7 Component
      • 5.3.2.8 Process
      • 5.3.2.9 Functionality
      • 5.3.2.10 Equipment
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Application
      • 5.3.3.6 End User
      • 5.3.3.7 Component
      • 5.3.3.8 Process
      • 5.3.3.9 Functionality
      • 5.3.3.10 Equipment
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Application
      • 5.4.1.6 End User
      • 5.4.1.7 Component
      • 5.4.1.8 Process
      • 5.4.1.9 Functionality
      • 5.4.1.10 Equipment
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Application
      • 5.4.2.6 End User
      • 5.4.2.7 Component
      • 5.4.2.8 Process
      • 5.4.2.9 Functionality
      • 5.4.2.10 Equipment
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Application
      • 5.4.3.6 End User
      • 5.4.3.7 Component
      • 5.4.3.8 Process
      • 5.4.3.9 Functionality
      • 5.4.3.10 Equipment
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Application
      • 5.4.4.6 End User
      • 5.4.4.7 Component
      • 5.4.4.8 Process
      • 5.4.4.9 Functionality
      • 5.4.4.10 Equipment
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Application
      • 5.4.5.6 End User
      • 5.4.5.7 Component
      • 5.4.5.8 Process
      • 5.4.5.9 Functionality
      • 5.4.5.10 Equipment
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Application
      • 5.4.6.6 End User
      • 5.4.6.7 Component
      • 5.4.6.8 Process
      • 5.4.6.9 Functionality
      • 5.4.6.10 Equipment
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Application
      • 5.4.7.6 End User
      • 5.4.7.7 Component
      • 5.4.7.8 Process
      • 5.4.7.9 Functionality
      • 5.4.7.10 Equipment
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Application
      • 5.5.1.6 End User
      • 5.5.1.7 Component
      • 5.5.1.8 Process
      • 5.5.1.9 Functionality
      • 5.5.1.10 Equipment
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Application
      • 5.5.2.6 End User
      • 5.5.2.7 Component
      • 5.5.2.8 Process
      • 5.5.2.9 Functionality
      • 5.5.2.10 Equipment
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Application
      • 5.5.3.6 End User
      • 5.5.3.7 Component
      • 5.5.3.8 Process
      • 5.5.3.9 Functionality
      • 5.5.3.10 Equipment
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Application
      • 5.5.4.6 End User
      • 5.5.4.7 Component
      • 5.5.4.8 Process
      • 5.5.4.9 Functionality
      • 5.5.4.10 Equipment
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Application
      • 5.5.5.6 End User
      • 5.5.5.7 Component
      • 5.5.5.8 Process
      • 5.5.5.9 Functionality
      • 5.5.5.10 Equipment
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Application
      • 5.5.6.6 End User
      • 5.5.6.7 Component
      • 5.5.6.8 Process
      • 5.5.6.9 Functionality
      • 5.5.6.10 Equipment
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Application
      • 5.6.1.6 End User
      • 5.6.1.7 Component
      • 5.6.1.8 Process
      • 5.6.1.9 Functionality
      • 5.6.1.10 Equipment
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Application
      • 5.6.2.6 End User
      • 5.6.2.7 Component
      • 5.6.2.8 Process
      • 5.6.2.9 Functionality
      • 5.6.2.10 Equipment
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Application
      • 5.6.3.6 End User
      • 5.6.3.7 Component
      • 5.6.3.8 Process
      • 5.6.3.9 Functionality
      • 5.6.3.10 Equipment
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Application
      • 5.6.4.6 End User
      • 5.6.4.7 Component
      • 5.6.4.8 Process
      • 5.6.4.9 Functionality
      • 5.6.4.10 Equipment
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Application
      • 5.6.5.6 End User
      • 5.6.5.7 Component
      • 5.6.5.8 Process
      • 5.6.5.9 Functionality
      • 5.6.5.10 Equipment

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Editas Medicine
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Intellia Therapeutics
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 CRISPR Therapeutics
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Beam Therapeutics
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Sangamo Therapeutics
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Precision Bio Sciences
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Caribou Biosciences
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Cellectis
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Gen Edit
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Poseida Therapeutics
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Horizon Discovery
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Inscripta
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Synthego
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Mammoth Biosciences
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 e Genesis
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Ori Gene Technologies
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Agenovir Corporation
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Recombinetics
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Telesis Bio
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Pairwise
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us